Short-Term Cannabis Use May Help Patients With Chronic Pain Maintain Sleep
Patients with chronic pain using medical cannabis reported less nighttime awakenings initially, but tolerance may build with frequent use.
Preemptive Pain Management Reduces Opioid Use After Minimally Invasive Surgery
A preemptive pain management program involving OTC medications can help reduce the need for opioid prescriptions following certain surgeries.
Lefamulin (Xenleta) for Community Acquired Bacterial Pneumonia
Lefamulin was approved by the FDA in August 2019 for the treatment of CABP.
Olaparib Granted Priority Review for HRR-Mutated Metastatic Castration-Resistant Prostate Cancer
FDA approval decision expected in the second quarter of 2020.
PPI Use May Affect Cognition in Individuals Previously Treated for Breast Cancer
Proton pump inhibitors (PPIs) may be linked to concentration and memory problems in individuals with a history of breast cancer.
Sunosi for Excessive Sleepiness in Adults with Narcolepsy or Obstructive Sleep Apnea
Solriamfetol (Sunosi, Jazz Pharmaceuticals) to treat excessive sleepiness in adult patients with narcolepsy or obstructive sleep apnea was approved on March 20, 2019.
FDA OKs Cardiovascular Risk Reduction Indication for Semaglutide
The FDA has approved semaglutide (Ozempic, Novo Nordisk) for the reduction of major adverse cardiovascular (CV) events in patients with type 2 diabetes and established CV disease.
What Pharmacists Need to Know About Psoriasis Medications
Pharmacists can play an integral role in managing patients with psoriasis through medication therapies and lifestyle modifications.
Diabetes a Serious Risk Factor for Herpes Zoster
Shingles vaccination recommended by CDC and ADCES.
Effect of Long-Term Antipsychotic Use on Morbidity, Mortality Risk
Antipsychotics were not associated with an increased risk of morbidity and mortality in patients with schizophrenia in a new study.
Most Valuable Drugs in the 2020 Pipeline
Here are the top drugs expected to be approved this year.
Cardiovascular Disease Linked to Increased Risk of Kidney Failure
Individuals with a history of heart disease may be at an increased risk of developing kidney failure.
WHO Insulin Prequalification Program to Expand Access
Cancer Mortality Continues Decline, Progress Driven by New Treatments
Overall cancer death rates declined by 29% over a 26-year time period, with the largest single-year drop on record reported from 2016 to 2017.
Prediabetes On the Rise Among US Teens and Young Adults
Prediabetes can increase the risk the risk of developing type 2 diabetes.
Intensive or Standard Blood Pressure Control for Patients Aged 80 and Older
Are the benefits of lowering systolic blood pressure to less than 130 mm Hg the same for those aged 80 years and older as they are for younger patients?
Dapagliflozin Granted Priority Review for Heart Failure with Reduced Ejection Fraction
AstraZeneca’s supplemental New Drug Application for dapagliflozin (Farxiga) has been granted Priority Review by the FDA.
FDA OKs Fast-Acting Insulin Aspart Injection for Children with Diabetes
Insulin aspart injection (Fiasp, Novo Nordisk) has been approved for use as a new mealtime insulin option for children with diabetes.
FDA Issues Complete Response Letter to Investigational Long-Acting HIV Regimen
The New Drug Application is seeking approval for ViiV Healthcare’s cabotegravir and Janssen’s rilpivirine for the treatment of HIV in adults.
Novo Nordisk Announces New Insulin Affordability Options
Due to ongoing insulin affordability challenges, Novo Nordisk is offering new cost assistance options for patients with diabetes.
Diabetes an Independent Risk Factor for Heart Failure
A new study examined diabetes as an independent predictor of heart failure.
FDA Approves Maintenance Olaparib for Metastatic Pancreatic Cancer
Olaparib (Lynparza, Merck and AstraZeneca) is approved for the maintenance treatment of adult patients with germline BRCA-mutated metastatic pancreatic cancer.
Recommended Vaccines for Patients with Diabetes
Patients with diabetes are at risk for complications from vaccine-preventable diseases, making immunization especially critical.
FDA Approves Generic Versions of Apixaban
The approvals were granted to generic apixaban applications from Micro Labs Limited and Mylan Pharmaceuticals Inc.
Top FDA Drug Approvals from 2019
Our most-read FDA approval articles from 2019.
Drug Shortages, Product Standardization Plague IV Drug Delivery
Ongoing threats to the safety of intravenous (IV) drug delivery include drug shortages and lack of IV product standardization, according to an expert panel.
Pharmacist and Physician Communication: We Can Do Better
Initiating conversation takes time and effort.
Study: Invasive Procedures Not Better than Meds for Cardiac Events
Invasive methods did not perform better than drug treatment in patients with stable ischemic heart disease
FDA Approves Novel Acute Migraine Treatment
Ubrogepant (Ubrelvy) is the first oral calcitonin gene-related peptide receptor antagonist approved by the FDA for the acute treatment of migraine.
FDA OKs New Treatment Option for Previously-Treated HER2-Positive Breast Cancer
Fam-trastuzumab deruxtecan-nxki (Enhertu, Daiichi Sankyo and AstraZeneca) is a new treatment option for patients with HER2-positive breast cancer who have progressed after 2 or more prior regimens.
